GLG Partners’s AbbVie ABBV Stock Holding History

GLG Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$183K	Sell	1,890 -1,471	-44%	-$139K	0.01%	385
2017 Q3	$299K	Buy	+3,361	New	+$256K	0.02%	291
2016 Q1	–	Sell	-2,300	Closed	-$136K	–	401
2015 Q4	$136K	Buy	+2,300	New	+$132K	﹤0.01%	420
2015 Q2	–	Sell	-18,454	Closed	-$1.08M	–	450
2015 Q1	$1.08M	Buy	+18,454	New	+$1.11M	0.04%	293
2014 Q4	–	Sell	-306,788	Closed	-$17.7M	–	389
2014 Q3	$17.7M	Buy	306,788 +219,367	+251%	+$12.2M	0.41%	73
2014 Q2	$4.93M	Sell	87,421 -152,131	-64%	-$7.98M	0.12%	186
2014 Q1	$12.3M	Buy	+239,552	New	+$12.1M	0.24%	118
2013 Q3	–	Sell	-276,991	Closed	-$11.5M	–	171
2013 Q2	$11.5M	Buy	+276,991	New	+$12.1M	0.44%	74

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

GLG Partners's ABBV Position: Q4 2017 in Review

GLG Partners reduced its AbbVie (ABBV) stake by 44% in Q4 2017, selling an estimated $139K and leaving 1,890 shares worth $183K. The position accounts for 0.01% of the portfolio, ranked #385.

GLG Partners first reported a position in ABBV in Q2 2013 and has held it in 8 quarters since. The position peaked at $17.7M in Q3 2014. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

GLG Partners held 1,890 shares of AbbVie worth $183K as of Q4 2017.
GLG Partners sold 1,471 AbbVie shares in Q4 2017, an estimated $139K.
AbbVie made up 0.01% of GLG Partners's portfolio in Q4 2017, its #385 holding.
GLG Partners first reported a position in AbbVie in Q2 2013 and has held it in 8 quarters since.
GLG Partners's AbbVie position peaked at $17.7M in Q3 2014.
2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.